Mologen AG Announces Results Of First Nine Months 2006 And Out-Licensing Agreement For Asia

The Berlin-based biotechnology company MOLOGEN announced today that it has entered an agreement with “China Import-Marketing und Promotion GmbH”, Cologne (C.I.P.) for licensing and distributing its innovative cell-based gene therapy in Asia.